Your Location:
Home >
Browse articles >
Mechanism of Erzhiwan on Hepatocellular Carcinoma Based on Network Pharmacology
Mechanism of Erzhiwan on Hepatocellular Carcinoma Based on Network Pharmacology
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 3, Pages: 166-174(2020)
DOI: 10.13422/j.cnki.syfjx.20192126
Scan QR Code
Full Text(HTML)
Figs( 8 ) Tabs( 2 )
References
Publication Info
Metrics
66
Views
70
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Investigation on Anti-liver Cancer Potential and Compatibility Characteristics of Fufang Biejia Ruangan Pian from Network Perspective
Molecular Mechanism of Erzhiwan in Inhibiting Benign Prostatic Hyperplasia Base on Network Pharmacology
Network Prediction of Active Ingredient-target-pathway of Erzhiwan Against Liver Fibrosis
Material Basis of Entada phaseoloides Against Neuropathic Pain Based on in vitro Chemical Profiling and in vivo Absorbed Constituents
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Related Author
Wen-jia CHEN
Xia MAO
Xiao-dong GUO
Ling-xiang YU
Na LIN
Yan-qiong ZHANG
Rui TAO
Guan-wei FAN
Related Institution
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
The Fifth Medical Center of PLA General Hospital
Tianjin University of Traditional Chinese Medicine (TCM), Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin Key Laboratory of TCM Pharmacology
The First Affiliated Hospital of Tianjin University of TCM
Dongzhimen Hospital, Beijing University of Chinese Medicine


